Moreover, weight gain and peripheral edema are well-known side effects of TZD, which may limit the role of TZD in the treatment of patients with NAFLD
Humira (adalimumab) Disease area(s): Immunology Manufacturer(s): AbbVie 2024 Sales (USD): $8.99 billion Why it sold so well: In 2024, Humira remained a significant revenue contributor for AbbVie, despite facing substantial declines due to biosimilar competition following its US loss of exclusivity in January 2023
Barros, E
Additionally, some individuals may experience muscle and joint pain, often accompanied by stiffness or discomfort
Ideal for improving energy levels and promoting cellular health, our Detox Drip is tailored to meet individual health goals and enhance overall vitality
The same principle applies when switching between semaglutide and tirzepatide , though that requires dose recalculation since the medications are not milligram-equivalent